CY1117112T1 - METHODS FOR CLEANING TRANS - (-) - DELTA9-tetrahydrocannabinol AND TRANS - (+) - DELTA9-tetrahydrocannabinol - Google Patents
METHODS FOR CLEANING TRANS - (-) - DELTA9-tetrahydrocannabinol AND TRANS - (+) - DELTA9-tetrahydrocannabinolInfo
- Publication number
- CY1117112T1 CY1117112T1 CY20161100024T CY161100024T CY1117112T1 CY 1117112 T1 CY1117112 T1 CY 1117112T1 CY 20161100024 T CY20161100024 T CY 20161100024T CY 161100024 T CY161100024 T CY 161100024T CY 1117112 T1 CY1117112 T1 CY 1117112T1
- Authority
- CY
- Cyprus
- Prior art keywords
- tetrahydrocannabinol
- trans
- delta9
- methods
- cleaning
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Εδώ περιγράφονται μέθοδοι για την παρασκευή trans(-)-Δ9-τετραϋδροκανναβινόλης και trans-(+)-Δ9-τετραϋδροκανναβινόλης. Σε μια ενσωμάτωση, μια σύνθεση trans-(-)-Δ9-τετραϋδροκανναβινόλης παρασκευάζεται επιτρέποντας σε μια σύνθεση που περιέχει (±)-Δ9-τετραϋδροκανναβινόλη να διαχωριστεί σε μια χειρόμορφη στατική φάση για την παροχή μιας σύνθεσης trans-(-)-Δ9-τετραϋδροκανναβινόλης που περιέχει τουλάχιστον περίπου 99% κατά βάρος trans-(-)-Δ9-τετραϋδροκανναβινόλη με βάση τη συνολική ποσότητα trans-(-)-Δ9-τετραϋδροκανναβινόλης και trans-(+)-Δ9-τετραϋδροκανναβινόλης. Η εφεύρεση αναφέρεται επίσης σε μεθόδους για τη θεραπεία ή πρόληψη μιας κατάστασης όπως άλγος οι οποίες μέθοδοι περιλαμβάνουν τη χορήγηση σε έναν ασθενή που χρήζει αυτής μιας αποτελεσματικής ποσότητας από μια trans-(-)-Δ9-τετραϋδροκανναβινόλη έχουσα καθαρότητα τουλάχιστον περίπου 98% με βάση το συνολικό βάρος κανναβινοειδών.Methods for preparing trans (-) - Δ9-tetrahydrocannabinol and trans - (+) - Δ9-tetrahydrocannabinol are described herein. In one embodiment, a trans - (-) - Δ9-tetrahydrocannabinol composition is prepared by allowing a composition containing (±) -Δ9-tetrahydrocannabinol to be separated in a chiral static phase to provide a trans - (-) - Δ9-tetrahydrocannabinol composition. containing at least about 99% by weight of trans - (-) - Δ9-tetrahydrocannabinol based on the total amount of trans - (-) - Δ9-tetrahydrocannabinol and trans - (+) - Δ9-tetrahydrocannabinol. The invention also relates to methods for treating or preventing a condition such as pain which methods include administering to a patient in need of an effective amount of a trans - (-) - Δ9-tetrahydrocannabinol having a purity of at least about 98% based on total weight of cannabinoids.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63055604A | 2004-11-22 | 2004-11-22 | |
EP10179360.2A EP2289509B1 (en) | 2004-11-22 | 2005-11-18 | Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1117112T1 true CY1117112T1 (en) | 2017-04-05 |
Family
ID=58487054
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20161100024T CY1117112T1 (en) | 2004-11-22 | 2016-01-12 | METHODS FOR CLEANING TRANS - (-) - DELTA9-tetrahydrocannabinol AND TRANS - (+) - DELTA9-tetrahydrocannabinol |
CY20161100264T CY1117343T1 (en) | 2004-11-22 | 2016-03-31 | METHODS FOR CLEANING TRANS - (-) - D9-tetrahydrocannabinol AND TRANS - (+) - D9-tetrahydrocannabinol |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20161100264T CY1117343T1 (en) | 2004-11-22 | 2016-03-31 | METHODS FOR CLEANING TRANS - (-) - D9-tetrahydrocannabinol AND TRANS - (+) - D9-tetrahydrocannabinol |
Country Status (1)
Country | Link |
---|---|
CY (2) | CY1117112T1 (en) |
-
2016
- 2016-01-12 CY CY20161100024T patent/CY1117112T1/en unknown
- 2016-03-31 CY CY20161100264T patent/CY1117343T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CY1117343T1 (en) | 2017-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111471T1 (en) | METHODS FOR CLEANING TRANS - (-) - D9-tetrahydrocannabinol AND TRANS - (+) - D9 tetrahydrocannabinol | |
EA200800056A1 (en) | CANNABINOID ACTIVE PHARMACEUTICAL INGREDIENT FOR MEDICINAL FORMS | |
CY1118148T1 (en) | COMPOSITION CONTAINING QUANTITATIVE AMMONIUM UNITS | |
CY1105922T1 (en) | USE OF SUBSTITUTED AZETIDINONE DERIVATIVES IN THE TREATMENT OF ALZHEIMER'S DISEASE | |
DE602005020269D1 (en) | USE OF TREPROSTINIL FOR THE TREATMENT OF NEUROPATHIC DIABETIC FOOTPROMMENTS | |
CY1115026T1 (en) | COMPOSITIONS CONTAINING ADDITIONAL FAT BLOCKS AND METHODS FOR USE | |
CY1115690T1 (en) | ARTHROSPIRA BASED COMPOSITIONS AND THEIR USES | |
EA200800413A1 (en) | NEW MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | |
CY1116463T1 (en) | Combination therapy for the therapeutic treatment of Protein Deficiency Disorders | |
UY28955A1 (en) | NEW FLUOROGLYCOSIDE DERIVATIVES OF PIRAZOLES, MEDICINES CONTAINING THESE COMPOUNDS, AND THE USE OF THEMSELVES | |
BRPI0408784A (en) | method to use a compound | |
ECSP10010310A (en) | NEW COMPOUNDS AND COMPOSITIONS AND METHODS OF USE | |
CY1106457T1 (en) | PHARMACEUTICAL COMPOSITION FOR USE IN HORMONE REPLACEMENT THERAPY | |
CY1113809T1 (en) | Macrocyclic carboxylic acids and acylsulfonamide compounds as inhibitors of HCV replication | |
PA8609201A1 (en) | REPLACED PYRIDINONES | |
TN2009000180A1 (en) | NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF | |
UY28369A1 (en) | THERAPEUTIC AGENTS | |
GT200600398A (en) | ISOINDOL-IMIDA COMPOUNDS AND COMPOSITIONS INCLUDING THEM AND METHODS FOR USE | |
SV2004001690A (en) | NEW DERIVATIVES OF HETEROCICLIC FLUOROGLYCOSIDS, MEDICINES CONTAINING THESE COMPOUNDS, AND THE USE OF THE SAME | |
NI200600290A (en) | PIRAZOL DERIVATIVES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND USE PROCEDURES | |
CY1108070T1 (en) | KINOLINONINE PRODUCERS, AS TYROSINE MOTORS | |
UA89315C2 (en) | Butylbenzene phthalein intravenous emulsion | |
EA200802223A1 (en) | 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS | |
CY1108018T1 (en) | METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF RESISTANCE TO ANTIPHERENSIC DRUGS AND RELATED DISEASES | |
DE602006010738D1 (en) | PYRROLOÄ2,3-CÜPYRIDINDERIVATE |